A Phase II Trial of the Novel Serotonin Type 3 Receptor Antagonist Ramosetron in Japanese Male and Female Patients with Diarrhea-Predominant Irritable Bowel Syndrome

Publisher： Karger

E-ISSN： 1421-9867|77|3-4|225-235

ISSN： 0012-2823

Source： Digestion, Vol.77, Iss.3-4, 2008-06, pp. : 225-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome

By Matsueda Kei   Harasawa Shigeru   Hongo Michio   Hiwatashi Nobuo   Sasaki Daisuke  

Scandinavian Journal of Gastroenterology, Vol. 43, Iss. 10, 2008-01 ,pp. : 1202-1211

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of Crofelemer in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome Patients

By  

Digestion, Vol. 78, Iss. 4, 2008-12 ,pp. : 180-186

Karger

Access to resources Recommend Favorite

Patients with Constipation-Predominant Irritable Bowel Syndrome (IBS) May Have Elevated Serotonin Concentrations in Colonic Mucosa as Compared with Diarrhea-Predominant Patients and Subjects with Normal Bowel Habits

By  

Digestion, Vol. 63, Iss. 3, 2001-05 ,pp. : 188-194

Karger

Access to resources Recommend Favorite

Rectal Hypersensitivity Reduced by Acupoint TENS in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Study

By Xiao Wen-Bin   Liu Yu-Lan  

Digestive Diseases and Sciences, Vol. 49, Iss. 2, 2004-02 ,pp. : 312-319

Springer Publishing Company

Access to resources Recommend Favorite

Leaky Gut in Patients with Diarrhea-Predominant Irritable Bowel Syndrome and Inactive Ulcerative Colitis

By  

Digestion, Vol. 85, Iss. 1, 2011-12 ,pp. : 40-46

Karger

Access to resources Recommend Favorite